Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands
Tóm tắt
Từ khóa
Tài liệu tham khảo
Nicholson KG, Snacken R, Palache AM. Influenza immunization policies in Europe and the United States. Vaccine 1995;13:365–9.
Meynaar IA, Wout JW van’t, Vandenbroucke JP, Furth R van. Use of influenza vaccine in The Netherlands. BMJ 1991;303:508.
Fiebach N, Beckett W. Prevention of respiratory infections in adults. Arch Intern Med 1994;154:2545–57.
Nichol KL, Margolis KL, Lind A, et al. Side eVects associated with influenza vaccination in healthy working adults. A randomised, placebo-controlled trial. Arch Intern Med 1996;156:1546–50.
Govaert Th ME, Dinant GJ, Aretz K, Masurel N, Sprenger MJW, Knottnerus JA. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ 1993;307:988–90.
Albazzaz MK, Harvey JE, Grilli EA, Caul EO. Subunit influenza vaccination in adults with asthma: eVect on clinical state, airwayreactivity, and antibody response. BMJ 1987;294:1196–7.
Stenius-Aarniala B, Huttunen JK, Pyhälä R, et al. Lack of clinical exacerbations in adults with chronic asthma after immunisation with killed influenza virus. Chest 1986;89: 786–9.
Rothbarth PH, Kempen BM, Sprenger MJW. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. Am J Resp Crit Care Med 1995; 151:1682–6.
Nichol KL, Margolis KL, Wuorenma J, Sternberg T von. The eYcacy and cost-eVectiveness of vaccination against influenza among elderly persons in the community. N Engl J Med 1994;331:778–84.
Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994;121:947–52.
McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med 1993;153: 2105–11.
Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The eYcacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518–27.
Flemming DM, Watson JM, Nicholas S, Smith GE, Swan AV. Study on the eVectiveness of influenza vaccination in the elderly in the epidemic of 1989–90 using a general practice database. Epidemiol Infect 1995;115:581–9.
Ohmit SE, Monto AS. Influenza vaccine eVectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol 1995; 24:1240–8.
Govaert ThME, Thijs CTMCN, Masurel N, Sprenger MJW, Dinant GJ, Knottnerus JA. The eYcacy of influenza vaccination in elderly individuals. A randomized doubleblind placebo-controlled trial. JAMA 1994;272:1661–5.
Ahmed Ah, Nicholson KG, Nguyen-Van-Tam. Reduction in mortality associated with influenza vaccine during 1989–90 epidemic. Lancet 1995;346:591–5.
Fedson DS, Wadja A, Nicol JP, Hammond GW, Kaiser DL, Roos LL. Clinical eVectiveness of influenza vaccination in Manitoba. JAMA 1993;270:1956–61 19 Riddiough MA, Sisk JE, Bell JC. Influenza vaccination.
Fedson DS, Hannoun C, Leese J, et al. Influenza vaccination in 18 developed countries, 1980–1992. Vaccine 1995;13: 623–7.
Lamberts H, Wood M, eds. ICPC. International classification of primary care. Oxford: Oxford University Press, 1987.
Classification committee of WONCA. ICHPPC-2 defined. International classification of health problems in primary care. Oxford: Oxford University Press, 1983.
Hak E, Hermens RPMG van, Essen GA van, Kuyvenhoven MM, De Melker RA. Population-based prevention of influenza in Dutch general practice. Br J Gen Pract 1997;47:363–6.
Essen GA van, Sorgedrager YCG, Salemink GW, Govaert ThME, Hoogen JPH van den, Laan JR van der. NHG-Standaard Influenza en influenzavaccinatie. (NHG guidelines Influenza and influenza vaccination). Huisarts Wet 1993;36:342–6. (With abstract in English).
Beasley R, Coleman ED, Hermon Y, Holst PE, O’Donell TV, Tobias M. Viral respiratory tract infections and exacerbations of asthma in adult patients. Thorax 1988;43:679– 83.
Claas ECJ, Jong JC de, Bartelds AIM, Rimmelzwaan GF, Wijngaarden JK van, Osterhaus ADME. Influenza in het seizoen 1995/96; vaccinsamenstelling voor het seizoen 1996/97. (Influenza in the 1995/96 season; vaccine composition for the 1996/97 season). Ned Tijdschr Geneesk 1996;140:2047–50. (With abstract in English).
Connolly AM, Salmon RL, Williams DH. What are the complications of influenza and can they be prevented? Experience from the 1989 epidemic of H3N2 influenza A in general practice. BMJ 1993;306:1452–4.
Bainton D, Jones GR, Hole D. Influenza and ischaemic heart diseasea possible trigger for acute myocardial infarction? Int J Epidemiol 1978;7:231–9.
Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
Rutten FPH, Ineveld BM van, Ommen R van, Hout BA van, Huijsman R. Kostenberekening bij gezondheidszorgonderzoek. Richtlijnen voor de praktijk. (Calculating costs in health care research. Guidelines for practical use) Utrecht: Jan Van Arkel, 1993. (In Dutch).
Lamberts H, Brouwer HJ, Mohrs J. Reason for encounter-, episodeand proces-oriented standard output from the Transition project. Amsterdam: Department of General Practice, University of Amsterdam, 1991.
Tirimanna PRS, Schayck CP van, Otter JJ den, et al. Prevalence of asthma and COPD in general practice in 1992: Has it changed since 1977? Br J Gen Pract 1996;46:277– 81.
Perez-Tirse J, Gross PA. Review of cost-benefit analyses of influenza vaccine. PharmacoEconomics 1992;2:198–206.